FDANot Yet Classified · Drug · FDA event 99934; recall number pending · Recalled October 7, 2026

amazon recall — Aurobindo Pharma USA Inc

Agency report date: October 7, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named: amazon
Company / brand: Aurobindo Pharma USA
Lot / serial / date codes: Lot# ACD124048A, Exp Date: 11/30/2027.
Distribution: US Nationwide.

Agency product description and boundaries

amazon, Acetaminophen, Extra Strength, 500mg Caplets, 1000-count bottle, Distributed by: Amazon.com Services LLC, 410 Terry Avenue N., Seattle, WA 98109, Made in India, NDC 72288-692-01. UPC 1 95515 04888 0

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Discoloration: consumer complaints received for discolored tablets

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Affected product: amazon recall status

3. Open the official notice or contact

View the official FDA enforcement record (openFDA) ↗

Official recall ID: Not yet assigned by the FDA — identified by FDA event ID 99934
Brand: All Aurobindo Pharma USA recalls
Classification: Not Yet Classified
Units affected: 7,836 1000-count bottles
Recall status: Ongoing
Initiated: Voluntary: Firm initiated

Affected products

amazon recall status

Companies & origin

Recalling firm location: East Windsor, NJ, United States
Firm address: 279 Princeton Hightstown Rd, 08520-1401

Identifying details (verbatim from the notice)

Product codes / lots: Lot# ACD124048A, Exp Date: 11/30/2027.
Distribution: US Nationwide.
Firm notified the public via: Letter
FDA event ID: 99934
Recall initiated: September 18, 2026
FDA report date: October 7, 2026

Other drug recalls from around the same time

Thyroid Tablets recall — VITRUVIAS THERAPEUTICS INCFDA · September 23, 2026
0 recall — B BRAUN MEDICAL INCFDA · September 16, 2026
Epinephrine Injection recall — American Regent, Inc.FDA · September 16, 2026
Dextrose Injection recall — Baxter Healthcare CorporationFDA · September 16, 2026
Glutathione 200 mg/mL recall — OPTIMAL BALANCE PHARMACYFDA · September 9, 2026

Verify with the official sources:

CPSC — consumer products ↗ (aggregated here)
NHTSA — vehicles, car seats, tires ↗ (aggregated here; use NHTSA's VIN lookup to check a specific vehicle)
FDA — food, drugs, medical devices ↗ (aggregated here)
USDA FSIS — meat, poultry & processed egg products ↗ (not aggregated here)
Recalls.gov — the U.S. government’s all-agency portal ↗

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked October 22, 2026 at 12:00 PM UTC. Record retrieved October 22, 2026 at 12:00 PM UTC.

Report a data error on this page